These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16172449)

  • 1. Leukopenia and thrombocytopenia caused by thiazolidinediones.
    Digman C; Klein AK; Pittas AG
    Ann Intern Med; 2005 Sep; 143(6):465-6. PubMed ID: 16172449
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.
    Odom J; Williamson B; Carter L
    Am J Health Syst Pharm; 2008 Oct; 65(19):1846-50. PubMed ID: 18796427
    [No Abstract]   [Full Text] [Related]  

  • 3. Pioglitazone is a valid alternative to rosiglitazone.
    Derosa G
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):357-62. PubMed ID: 21950735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes: making sense of the rosiglitazone controversy.
    Farkouh ME; Fuster V
    Nat Rev Cardiol; 2010 Jul; 7(7):366-7. PubMed ID: 20577297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics.
    Ratner RE; Cannon CP; Gerstein HC; Nesto RW; Serruys PW; Van Es GA; Kolatkar NS; Kravitz BG; Zalewski A; Fitzgerald PJ;
    Am Heart J; 2008 Dec; 156(6):1074-9. PubMed ID: 19033001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
    Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
    Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone and pioglitazone. Beware fractures.
    Dixit A; Pandey P
    BMJ; 2009 Sep; 339():b3957. PubMed ID: 19808816
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosiglitazone or pioglitazone in type 2 diabetes?
    de Vries CS; Russell-Jones DL
    BMJ; 2009 Aug; 339():b3076. PubMed ID: 19690344
    [No Abstract]   [Full Text] [Related]  

  • 9. Thiazolidinediones: antidiabetic agents with effects on bone.
    Debiais F
    Joint Bone Spine; 2009 May; 76(3):221-3. PubMed ID: 19362505
    [No Abstract]   [Full Text] [Related]  

  • 10. Thiazolidinediones: do harms outweigh benefits?
    Lipscombe LL
    CMAJ; 2009 Jan; 180(1):16-7. PubMed ID: 19073650
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Janoo G; Teeluck AR; Huang F
    BMC Pharmacol Toxicol; 2017 Oct; 18(1):66. PubMed ID: 29058622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone and rosiglitazone for diabetes.
    Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Options sought after drug study. Patients who take rosiglitazone might consider pioglitazone instead.
    Heart Advis; 2007 Jul; 10(7):9. PubMed ID: 17703512
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse effect of pioglitazone in military personnel and their families: a preliminary report.
    Vudhironarit T; Benjasuratwong Y; Patarakitvanit S; Temboonkiat S; Satyapan N
    J Med Assoc Thai; 2009 Feb; 92 Suppl 1():S124-8. PubMed ID: 21299185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
    Krentz AJ; Bailey CJ; Melander A
    BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value equation for rosiglitazone and pioglitazone in older persons.
    Zarowitz BJ
    Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172
    [No Abstract]   [Full Text] [Related]  

  • 18. Mild, reversible pancytopenia induced by rosiglitazone.
    Maaravi Y; Stessman J
    Diabetes Care; 2005 Jun; 28(6):1536. PubMed ID: 15920093
    [No Abstract]   [Full Text] [Related]  

  • 19. [Doubts as to the cardiovascular safety of rosiglitazone].
    Hoekstra JB; Bossuyt PM; de Vries JH
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1449-50. PubMed ID: 17633972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of thiazolidinediones.
    Tolman KG
    Expert Opin Drug Saf; 2011 May; 10(3):419-28. PubMed ID: 21366501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.